Minority / Underserved – Diversity, Equity & Inclusion
While Cures Within Reach is disease-agnostic and geography-agnostic, some of our funding partners have strategic interests in specific population groups. Therefore, in addition to our disease-specific and geographic repurposing communities, we have a Minority and Underserved Repurposing Community to support Diversity, Equity & Inclusion (DEI) efforts that utilizes the speed and cost-effectiveness of testing already approved therapies in new indications to improve the quality and length of life of minority and underserved patients as well as to support minority and underserved researchers.
We support Diversity, Equity & Inclusion efforts by finding and funding clinical repurposing projects:
- Led by Minority and Underserved Researchers in any disease area
- To positively impact Health Disparities within communities of color
- To impact patients living in low and low-middle income countries (LMICs, as defined by the World Bank)
Open Funding Opportunities in Diversity, Equity & Inclusion:
- Repurposing Research Led by a US-Based Under-Represented Racial Minority Principal Investigator: at least 3 grants of up to $70,000 each for clinical repurposing trials in any disease led by a US-based under-represented racial / ethnic minority PI, as defined by the NIH. EXTENDED: Proposal submissions due July 30, 2021.
- Repurposing Research to Address Racial / Ethnic Health Disparities in the Greater Chicago Area: at least 3 grants of up to $80,000 each for clinical repurposing trials from any research institution in the greater Chicago area to address racial / ethnic health disparities in communities of color as defined by the NIH. Proposal submissions due July 30, 2021.
- ReGRoW: Repurposing Grants for the Rest of the World – Funding for Underserved Researchers in Low and Lower-Middle Income Countries (LMICs): at least 3 grants of up to $50,000 each for clinical repurposing trials led by underserved researchers in LMICs to impact patients in LMICs, as defined by the World Bank. Proposal submissions due August 6, 2021.
More information on our Funding Opportunities / RFPs page.
As we develop and grow this Community, Cures Within Reach thanks our early funding partners:
for its support of our first project in Health Disparities: “Can Vitamin D reduce the burden of COVID-19?” focusing on Black and Hispanic Chicagoans,
for its support of Minority and Underserved communities and researchers, including:
- Repurposing Fecal Microbiota Transplantation for the Treatment of Pediatric Malnutrition in South Africa (completed)
- Treating Tuberculosis with a Lipid Lowering Drug in Nigeria
- Testing the Safety of a Repurposed Drug to Treat Snakebite in Kenya
- Improving Outcomes for the Rare Liver Disease Biliary Atresia with a Cancer Drug in Vietnam
- Infectious disease in Kenya: pending
Current DEI – Minority / Underserved Research(er) Projects
Events and Media
Learn about our Health Disparities project in COVID-19 focused on Black and Latinx communities by watching Dr. Meltzer of University of Chicago interviewed on ABC7 Chicago and Fox Chicago and reading more in the Chicago Tribune.
Cure Accelerator Live! for Chicago 2020
Four finalists from Chicago-based institutions competing for up to $50,000 to fund their repurposing clinical trials, including a minority-led project. Watch Dr. Lindsey pitch his project.
CureAccelerator Live! for Rare Diseases 2020
Five finalists from the US competing for up to $50,000 to fund their repurposing clinical trials impacting rare disease patients – including a minority led project. Read more about Dr. Phillips’ project and watch him pitch it.
CureAccelerator Live! for the Developing World 2019
Five finalists from the US and India competing for up to $50,000 to fund their repurposing clinical trials impacting patients in the Developing World.
Completed DEI – Minority / Underserved Research(er) Projects
(in the past 3 years)